Intravenous Colistin Use for Multidrug-Resistant Gram-Negative Infections in Pediatric Patients

about

Intravenous Colistin Use for Multidrug-Resistant Gram-Negative Infections in Pediatric Patients

Item

http://www.wikidata.org/entity/Q36229076

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Intravenous Colistin Use for M ...... fections in Pediatric Patients

@ast

Intravenous Colistin Use for M ...... fections in Pediatric Patients

@en

type

Item

label

Intravenous Colistin Use for M ...... fections in Pediatric Patients

@ast

Intravenous Colistin Use for M ...... fections in Pediatric Patients

@en

prefLabel

Intravenous Colistin Use for M ...... fections in Pediatric Patients

@ast

Intravenous Colistin Use for M ...... fections in Pediatric Patients

@en

P1476

Intravenous Colistin Use for M ...... fections in Pediatric Patients

@en

P2093

Ahmet Soysal

http://www.w3.org/2001/XMLSchema#string

Ayşe Karaaslan

http://www.w3.org/2001/XMLSchema#string

Eda Kepenekli Kadayifci

http://www.w3.org/2001/XMLSchema#string

Eren Çağan

http://www.w3.org/2001/XMLSchema#string

Gülşen Akkoç

http://www.w3.org/2001/XMLSchema#string

Mustafa Bakır

http://www.w3.org/2001/XMLSchema#string

Nurhayat Yakut

http://www.w3.org/2001/XMLSchema#string

Serkan Atıcı

http://www.w3.org/2001/XMLSchema#string

Sevliya Öcal Demir

http://www.w3.org/2001/XMLSchema#string

P2860

Toxicity after prolonged (more than four weeks) administration of intravenous colistin

Renal and neurological side effects of colistin in critically ill patients

Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.

Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria

High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.

Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

Systemic colistin use in children without cystic fibrosis: a systematic review of the literature.

P304

627-632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5152/BALKANMEDJ.2016.16210

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27994915

http://www.w3.org/2001/XMLSchema#string

P921

Gram-negative bacteria

multiple drug resistance

P932

5156448

http://www.w3.org/2001/XMLSchema#string